Invertebrate Oxygen Carrier Proteins in Immunology and Vaccine Research

Invertebrate oxygen carrier proteins are often large oligomeric complexes, combining stable metal-binding sites with abundant surface epitopes. Beyond oxygen transport, they are commonly used as strong immunogens, antigen carriers, and immune response-enhancing modules in immunology and vaccine research. Their effects are significantly influenced by source, glycosylation patterns, oligomeric state, and impurity background, necessitating material characterization and process quality control as methodological prerequisites.

Keywords: invertebrate; oxygen carrier protein; hemocyanin; carrier protein; adjuvant; innate immunity; antigen presentation; vaccine

I. Oxygen Carrier Protein Lineages and Immunology Interfaces

1.1 Major Types and Structural Organization

(1) Hemocyanin

Copper ions serve as the oxygen-binding centers; typically exist as high-molecular-weight oligomers with numerous surface-exposed sites and stable conformations, readily recognized by the immune system and inducing strong humoral responses.

(2) Invertebrate Hemoglobin-like Complexes

Some annelids and marine invertebrates contain extracellular giant hemoglobin complexes with highly aggregated multimeric structures and dense surface antigens, exhibiting distinct kinetics in immune recognition and phagocytic processing compared to conventional soluble proteins.

(3) Immunological Implications of Structure–Function

High molecular weight, repetitive epitopes, and stable oligomeric structures enhance antigen retention and uptake in lymphoid tissues and promote B-cell receptor crosslinking and germinal center responses, leading to high-titer antibodies and enhanced affinity maturation.

Name	Class/Source	Features
Hemocyanin (Hc)	Mollusks, Arthropods	Copper-binding oxygen carrier; blue when oxygenated; giant multimeric protein; immune-enhancing and antigen carrier properties.
Giant Extracellular Hemoglobin Complex (Erythrocruorin)	Annelids	Iron-binding oxygen carrier; multimeric high-order assembly; soluble extracellular complex; rich in repetitive structural units.
Hemerythrin (Hr)	Various marine invertebrates	Non-heme diiron oxygen-binding protein; purple to violet-red when oxygenated; oligomerization-dependent oxygen binding.
Hemovanadin	Tunicates (Ascidians)	Vanadium-binding protein; not directly transporting oxygen; associated with metal ion accumulation, redox microenvironments, and defense-related processes.
Hemocyanin-like Immune Proteins	Mollusks or crustacean-derived homologs	Structurally homologous or derived from hemocyanin; some members primarily immune-functional; applicable for immune stimulation or as antigen coupling and presentation enhancement modules.

1.2 Differentiated Value Compared with Vertebrate Oxygen Carriers

(1) Sequence and Epitope Novelty

Compared to mammalian hemoglobins, invertebrate oxygen carriers are highly heterologous for laboratory animals, readily inducing robust immune responses.

(2) Complexity of Glycosylation and Surface Modifications

Glycan structures and modifications provide additional recognition patterns, influencing dendritic cell uptake, complement deposition, and receptor-mediated endocytosis, thereby altering immune quality and bias.

(3) Contribution of Oligomeric State to Innate Immunity Triggering

High-order aggregation facilitates particle-like antigen presentation, enhancing phagocytosis and lysosomal processing, and under certain conditions, boosting inflammation-related signal initiation.

II. Immune Activation Mechanisms and Innate Immunity Interfaces

2.1 Pattern Recognition and Phagocytic Processing

(1) Surface Repetitive Structures and Particle-like Features

High-molecular-weight oligomers can act as particulate antigens at the cellular level, facilitating phagocytic uptake and lysosomal processing.

(2) Glycan-mediated Receptor Recognition

Specific glycan patterns interact with lectin-like receptors, affecting uptake efficiency, cytokine profiles, and antigen presentation strength.

(3) Complement and Opsonization

Protein surface structure and charge distribution influence complement deposition and opsonization, thereby altering antigen clearance and presentation efficiency.

2.2 Antigen Presentation and T Cell Helper Enhancement

(1) MHC II Presentation and CD4+ T Cell Activation

Under appropriate dose and handling conditions, oxygen carrier proteins can act as strong immunogens inducing robust CD4+ T cell help, significantly enhancing humoral response quality against co-delivered antigens.

(2) Potential Contribution of Cross-Presentation

When antigens are internalized as particulate or complexed forms, some can enter cross-presentation pathways, supporting CD8+ T cell studies, dependent on cell type, delivery format, and inflammatory context.

(3) Germinal Center Responses and Affinity Maturation

Strong Tfh support and prolonged antigen retention promote sustained germinal center responses, facilitating antibody affinity maturation and isotype switching.

III. Vaccine-relevant Value as Carrier Proteins

3.1 Immune Enhancement for Peptides and Small Molecules

(1) Addressing Weak Immunogenicity

Short peptides, carbohydrates, lipids, and small molecule haptens often lack sufficient T-cell epitopes or antigen presentation efficiency; direct immunization usually induces low-titer or unstable responses. Conjugation with oxygen carrier proteins provides abundant T-cell helper epitopes and increases antigen density.

(2) B-cell Receptor Crosslinking and Activation Threshold Reduction

Multiple copies of target epitopes displayed on large carrier surfaces facilitate effective BCR crosslinking, increasing initial activation probability and clonal expansion.

(3) Isotype Switching and Durability Enhancement

Carrier-induced T cell help promotes IgG isotype switching and long-lived plasma cell formation, enhancing antibody persistence and functionality.

3.2 Conjugation Strategy and Epitope Fidelity

(1) Impact of Conjugation Chemistry on Epitope Structure

Choice of conjugation site and linker length may alter spatial presentation of key epitopes, affecting antibody specificity and neutralization capacity.

(2) Conjugation Density and Immune Bias

Excessive conjugation density may mask or distort epitopes, while too low density reduces BCR crosslinking efficiency; small-scale optimization is necessary to identify effective windows.

(3) Quality Attributes and Batch Consistency

Distribution of conjugation, residual free antigen, oligomeric state changes, and impurity background significantly affect immune readouts and should be monitored as critical quality attributes.

IV. Adjuvant-like Effects and Immune Response Shaping

4.1 Complementarity with Classical Adjuvants

(1) Carrier Provides T Cell Help, Adjuvants Provide Inflammatory Signal

Carrier proteins mainly address antigen presentation and helper function; classical adjuvants provide danger signals and local inflammatory microenvironment; their combination enhances response intensity and quality.

(2) Response Bias under Different Adjuvant Systems

Depending on adjuvant context, carrier-conjugated antigens may show different Th polarization and antibody isotype profiles; experimental design should align with target immune type and adjuvant strategy.

(3) Balancing Reactogenicity and Tolerance

Highly immunogenic carriers may increase local reactogenicity or non-specific inflammation under certain conditions, requiring optimization of dose, administration route, and immunization interval.

4.2 Innate Immunity Readouts and Mechanistic Validation

(1) Cytokine Profiles and Co-stimulatory Molecules

Markers of dendritic cell maturation, cytokine profiles, and co-stimulatory molecule expression can assess innate immune activation elicited by the carrier.

(2) Uptake and Intracellular Localization

Confocal or flow-based uptake experiments can compare different formulations in terms of phagocytosis and lysosomal localization, supporting mechanistic attribution.

(3) Distinguishing Complement- and Fc-mediated Effects

If immune amplification is observed, it is important to distinguish contributions from complement opsonization, Fc receptor-mediated uptake, or purely T cell help, avoiding misattribution of overlapping mechanisms.

V. Immunodetection and Methodological Platform Applications

5.1 Antibody Generation and Immunoreagent Construction

(1) As Immunogen to Enhance Antibody Generation

Conjugating small molecule or short peptide antigens to oxygen carrier proteins significantly increases antibody titer and the likelihood of obtaining high-affinity antibodies.

(2) Establishing Competitive Detection Systems

Hapten antibodies are often used in ELISA or other immunoassays; carrier conjugation strategies influence specificity windows and cross-reactivity spectra, requiring systematic optimization.

(3) Platform QC in Immunological Methodology

When carrier protein immunogenicity is high and batch differences controllable, they can serve as internal reference materials to assess immunization process stability and inter-animal variability.

5.2 Model Antigen for Immune Mechanism Studies

(1) B Cell and Germinal Center Research Model

Highly immunogenic proteins can construct stable germinal center response models to evaluate Tfh support, affinity maturation, and plasma cell differentiation kinetics.

(2) Antigen Retention and Lymph Node Microenvironment Studies

Large molecular antigens’ retention in follicular dendritic networks can model sustained antigen presentation and immune memory formation.

(3) Tolerance and Anti-Carrier Effects Studies

Repeated immunization may induce anti-carrier antibodies, affecting subsequent same-carrier antigen responses; this phenomenon can be used to study anti-carrier effects and immune intervention strategies.

VI. Multi-Enzyme and Multi-Module Integration in Vaccine Research

6.1 Coupling with Protein Processing and Conjugation

(1) Protease Use for Epitope Exposure and Fragment Design

Controlled protease treatment can generate specific fragments or expose epitopes, facilitating more controllable conjugation and immune presentation.

(2) Glycan Processing and Glycoengineering

Enzymatic deglycosylation or glycoengineering can study glycan–immune effect relationships while maintaining protein oligomer stability and controlling aggregation.

(3) Multi-Enzyme Workflow Effects on Quality Attributes

Processing workflows may introduce aggregation, oxidation, or residual enzyme contamination; consistent QC metrics should be established before and after conjugation.

6.2 Integration with Delivery Systems

(1) Nanoparticle and Liposome Delivery

Combining carrier–antigen complexes with delivery systems can alter lymphoid tissue distribution and cellular uptake pathways, influencing response strength and polarization.

(2) Mucosal Delivery and Local Immunity

In mucosal immunology studies, carrier protein stability and local barrier penetration must be optimized in conjunction with delivery systems.

(3) Risk Management for Combination Strategies

Delivery systems may alter protein conformation, expose hydrophobic surfaces, and induce aggregation, affecting immune specificity and reactogenicity; process control via particle size distribution and aggregation state is required.

VII. Critical Variables, Risk Control, and Experimental Design Considerations

7.1 Material-Level Critical Quality Attributes

(1) Oligomeric State and Aggregate Distribution

Oligomeric state determines epitope density and particulate features; monitoring should be performed by size measurement, SEC, or other characterization methods.

(2) Glycosylation Patterns and Terminal Modification Ratios

Glycan differences may alter uptake and clearance pathways; establishing correspondence between glycocharacterization and functional readouts is necessary.

(3) Endotoxin and Impurity Background

Trace endotoxins can amplify innate immune readouts; background must be controlled through detection and removal to avoid misinterpretation of mechanisms.

7.2 Systematic Design of Immunization and Readout Schemes

(1) Administration Route, Dose, and Interval

Different administration routes significantly affect antigen retention and cell recruitment; parameters must match research goals and be optimized.

(2) Antibody Quality, Not Just Titer

Beyond titer, affinity maturation, isotype distribution, and functional readouts should be included to assess immune response quality.

(3) Management of Anti-Carrier Effects

Repeated immunization or concurrent projects may induce anti-carrier antibodies; experimental design should clarify whether carrier replacement or masking strategies are required.

VIII. Aladdin-Related Products

8.1 Invertebrate Oxygen Carrier Proteins and Their Conjugation/Labeling Preparations

Catalog No.	Product Name	Grade and Purity
S1518239	Shrimp Hemocyanin (SHC, Unactivated, KLH Alternative)	BioReagent，Native, ≥98%(SDS-PAGE)，from Penaeus vannamei
H1443352	Hemocyanin	≥98%
D1424967	2,4-D/KLH	—
O1439734	25-OH Vitamin D3/KLH	—
K1446538	Keyhole Limpet Hemocyanin-FITC	—
M1443720	Melamine/KLH	—
E1419637	Ethambutol-KLH	—
C1441418	Clenbuterol/KLH	—
R1420075	Rifampin/KLH	—
D1448555	DHT/KLH	—
P1418196	Pyrazinamide-KLH	—
I1418251	Isoniazid-KLH	—
P1441503	Periplogenin/KLH	—
A1443305	Alginic acid/KLH	—
B1447752	Biotin/KLH	—
T1440304	T3/KLH	—
M1442407	Metronidazole/KLH	—
R1440640	Ractopamine/KLH	—
H1443352	Hemocyanin	≥98%
S1446218	Streptomycin/KLH	—
A1417835	Aflatoxin B1/KLH	—

8.2 Summary of Auxiliary Reagents for Invertebrate Oxygen Carrier Protein Research

Name	CAS No.	Experimental Role	Key Use	Usage Notes
Copper(II) sulfate pentahydrate	7758-99-8	Metal Ion Supplement / Enzyme Activity Regulation	Provide metal center for copper-dependent oxygen carrier proteins or for in vitro activity validation	Control concentration to avoid protein precipitation or non-specific oxidation; match buffer system
Copper(II) chloride dihydrate	10125-13-0	Metal Ion Supplement / Enzyme Activity Regulation	Bind to hemocyanin or copper-dependent complexes to maintain oxygen carrier protein structure and activity	Avoid excess causing protein aggregation; strictly control solution pH
EDTA disodium salt	6381-92-6	Chelator / Metal Ion Regulation	Chelate free metal ions to verify metal dependency or remove contaminant metals	Control dose to avoid disrupting target protein Cu/Fe sites
EGTA	67-42-5	Chelator / Calcium-dependent Regulation	Block calcium-dependent interactions or immune complex formation	Adjust pH before use; avoid affecting oligomeric state of oxygen carrier protein
Sodium dithionite	7775-14-6	Antioxidant	Prevent oxidation-induced protein structure damage or antigen epitope alteration	Avoid excess affecting Cu/Fe redox state
L-Lactic acid	50-21-5	Buffer / Energy Simulation	Simulate cellular microenvironment or serve as buffer component	Control concentration to avoid pH drift
Uric acid	69-93-2	Antioxidant / Free Radical Regulation	Protect protein from oxidation or participate in in vitro oxidative stress models	Pay attention to solubility and pH matching
HEPES	7365-45-9	Buffer	Stabilize oxygen carrier protein pH in in vitro experiments	Fix concentration and temperature; avoid metal chelation affecting protein activity
Imidazole	288-32-4	Metal Ion Binding Regulation / Affinity Chromatography	Used for protein purification or to adjust metal-binding environment	Avoid high concentrations that induce protein dissociation or structural damage
L-Histidine	71-00-1	Buffer / Metal Binding Regulation	Serve as metal ion buffer or coordination agent to stabilize protein structure	Control pH and concentration; avoid interfering with immune analysis
Glutaraldehyde	111-30-8	Fixative / Crosslinking	Fix oxygen carrier protein or conjugate antigens for immunoassays	Use low concentration to prevent over-crosslinking; note toxicity and waste handling
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC·HCl)	25952-53-8	Conjugation Reagent	Conjugate oxygen carrier proteins with small molecules or peptide antigens	Control pH and reaction time; avoid excessive epitope disruption
N-Hydroxysuccinimide (NHS)	6066-82-6	Conjugation Enhancer	Work with EDC to increase conjugation efficiency and stability	Optimize pH for protein; avoid free NHS interfering with downstream immunoassays
SMCC	64987-85-5	Crosslinking Conjugation Agent	Conjugate oxygen carrier protein with thiol-containing antigens	Control ratio and reaction time; avoid aggregation
Sulfo-SMCC	92921-24-9	Water-soluble Crosslinking Agent	Similar to SMCC but suitable for aqueous-phase conjugation	Avoid high concentration affecting protein stability
2-Iminothiolane hydrochloride (Traut’s Reagent)	4781-83-3	Thiol Introduction Reagent	Introduce conjugatable thiols on protein to link antigens	Control molar ratio; avoid protein degradation
Dithiothreitol (DTT)	3483-12-3	Reducing Agent	Reduce disulfide bonds or adjust thiol status in oxygen carrier proteins	Avoid excess disrupting oligomeric state; short exposure time
TCEP·HCl	51805-45-9	Reducing Agent	Alternative to DTT to maintain protein thiol reduction	Control concentration and pH; avoid affecting Cu/Fe binding
L-Cysteine	52-90-4	Amino Acid / Conjugation Pretreatment	Provide conjugatable thiols or protect protein structure	Pay attention to pH and concentration
Glycine	56-40-6	Buffer / Reaction Termination	Terminate conjugation reactions or adjust pH	Use with conjugation system
Bovine Serum Albumin (BSA)	9048-46-8	Blocking / Stabilizer	Block non-specific binding, protect oxygen carrier protein or antigen	Dissolve fresh; keep concentration moderate
Polymyxin B sulfate	1405-20-5	Endotoxin Removal Agent	Reduce endotoxin background to minimize immune false positives	Control usage; check for residual
Trehalose	99-20-7	Stabilizer / Glycan Protection	Stabilize protein oligomer structure and protect glycan and antigen epitopes	Control concentration to avoid osmotic effects
Coomassie Brilliant Blue G-250	6104-58-1	Protein Quantification / Staining	SDS-PAGE or Bradford protein quantification staining	Avoid high concentration affecting protein function
Coomassie Brilliant Blue R-250	6104-59-2	Protein Quantification / Staining	Protein quantification or SDS-PAGE staining	Control staining concentration and duration

Invertebrate oxygen carrier proteins can be used as carrier proteins, immune-enhancing modules, and model antigens in immunology and vaccine research. Their effects and directionality are jointly determined by oligomeric state, glycosylation pattern, and impurity background. Based on structural characterization and process quality control, combined with multi-dimensional immune readouts and control strategies, results with higher interpretability and reproducibility can be achieved.

For more related articles, please see below:

[1] B Phenotypic detection of cells

[2] Polyclonal Antibody Preparation Experiment